- Chest X-Ray
- Nose or throat culture and test
- Blood Tests
The global whooping cough diagnostics market is growing at significant rate of CAGR of x% during the forecast period 2023 to 2029 owing to prevalence pertussis. There are many products which are under clinical trials. Whooping cough is also called as pertussis. It is an infection of respiratory system caused by bacterium Bordetella pertussis. It mainly affects babies younger than 6 months old who are not yet protected by immunizations and kids 11 to 18 years old whose immunity has started to fade. The whooping cough diagnostics market is expected to experience is a lucrative growth during the forecast period globally owing to the ongoing clinical trials and chances of many nearby approvals.
Whooping Cough Diagnostics Market Key Developments:
- For Instance, in 2014, Quidel Corporation received U.S FDA clearance to market its AmpliVue Bordetella Assay for the detection of Bordetella pertussis nucleic acids.
- In November 2015, Meridian Bioscience received U.S FDA clearance for new claims for its illumigene Pertussis molecular amplification test.
Whooping Cough Diagnostics Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
X%
Largest Market
North America
Fastest Growing Market
Europe
Whooping Cough Diagnostics Market Dynamics
The whooping cough causes severe coughing spells which end in a whooping sound when the child breathes in. Growing birthrate, rise in prevalence of whooping cough globally may propel the growth of the market. Furthermore, rise in initiatives taken by the government, growing awareness regarding whooping cough, favourable insurance policies and favourable reimbursements also boosts the market for the whooping cough diagnostics. Moreover, increase in awareness about whooping cough vaccination drives the market. As per to the WHO statistics in 2015, 126 countries had reached 90% coverage of diphtheria-tetanus-pertussis vaccine. However, lack of awareness in some regions, high cost of the diagnostic tests may hinder the growth of the market.
North America got significant share
Whooping Cough Diagnostics Market Regional Analysis
Geographically the Whooping Cough Diagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America leads the global whooping cough diagnostics market owing to increase in pertussis death rate in U.S. According to CDC in 2014 28,660 people were reported with pertussis in U.S. Europe also holds a significant position in whooping cough diagnostics market owing to the favourable reimbursement policies, well-established healthcare infrastructure. Asia Pacific and Latin America region are expected to experience a lucrative growth owing to the high birth rate, rise in per capita income of emerging economies, rise in initiatives and awareness campaigns regarding whooping cough and its prevention by government agencies and NGO's
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The whooping cough diagnostics market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Whooping Cough Diagnostics Market Segmentation
By Test
By End-User
- Hospitals
- Diagnostic Centers
- Clinics
By Geography
- Asia Pacific
- Europe
- Latin America
- North America
- Middle East and Africa
Frequently Asked Questions
The key segments covered in the whooping cough diagnostics market are: by test, by end user
The whooping cough diagnostics market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
Europe is the fastest-growing for whooping cough diagnostics market
| 1.Executive Summary |
| 2.Global Whooping Cough Diagnostics Market Introduction |
| 2.1.Global Whooping Cough Diagnostics Market - Taxonomy |
| 2.2.Global Whooping Cough Diagnostics Market - Definitions |
| 2.2.1.Test |
| 2.2.2.End User |
| 2.2.3.Region |
| 3.Global Whooping Cough Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Whooping Cough Diagnostics Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Whooping Cough Diagnostics Market By Test, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Chest X-Ray |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Nose or throat culture and test |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Blood Tests |
| 5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Whooping Cough Diagnostics Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Diagnostic Centers |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Clinics |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Whooping Cough Diagnostics Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Whooping Cough Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. Test Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Chest X-Ray |
| 8.1.2.Nose or throat culture and test |
| 8.1.3.Blood Tests |
| 8.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospitals |
| 8.2.2.Diagnostic Centers |
| 8.2.3.Clinics |
| 8.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Whooping Cough Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. Test Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Chest X-Ray |
| 9.1.2.Nose or throat culture and test |
| 9.1.3.Blood Tests |
| 9.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospitals |
| 9.2.2.Diagnostic Centers |
| 9.2.3.Clinics |
| 9.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10.Asia Pacific (APAC) Whooping Cough Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Test Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Chest X-Ray |
| 10.1.2.Nose or throat culture and test |
| 10.1.3.Blood Tests |
| 10.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospitals |
| 10.2.2.Diagnostic Centers |
| 10.2.3.Clinics |
| 10.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Whooping Cough Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Test Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Chest X-Ray |
| 11.1.2.Nose or throat culture and test |
| 11.1.3.Blood Tests |
| 11.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospitals |
| 11.2.2.Diagnostic Centers |
| 11.2.3.Clinics |
| 11.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Whooping Cough Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Test Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Chest X-Ray |
| 12.1.2.Nose or throat culture and test |
| 12.1.3.Blood Tests |
| 12.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospitals |
| 12.2.2.Diagnostic Centers |
| 12.2.3.Clinics |
| 12.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Meridian Biosciences Inc. (U.S.) |
| 13.2.2.Quidel Corporation (U.S.) |
| 13.2.3.Great Basin Scientific, Inc. (U.S.) |
| 13.2.4.Synthetic Biologics (U.S.) |
| 13.2.5.Quest Diagnostics (U.S.) |
| 13.2.6.Luminex (U.S,) |
| 13.2.7.Pulse Scientific Inc.(Canada) |
| 13.2.8.Diagenode Diagnostics (Belgium) |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
- Meridian Biosciences Inc. (U.S.)
- Quidel Corporation (U.S.)
- Great Basin Scientific, Inc. (U.S.)
- Synthetic Biologics (U.S.)
- Quest Diagnostics (U.S.)
- Luminex (U.S,)
- Pulse Scientific Inc.(Canada)
- Diagenode Diagnostics (Belgium)